Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
Min Chen(University of British Columbia), Xiaoyan Jiang(BC Cancer Agency)
Cited by 20
Related Papers
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes
|Transplantation and Cellular Therapy|2022|82
AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
|The Journal of Experimental Medicine|2008|72